Rebirth of the Strongest Tycoon

When it comes to the stock acquisition of listed companies, it requires Polaris Capital to have a special financial investment department.

In addition to Xia Yu, there is no one in the company who is more suitable than the future Wall Street investment guru Peter Lynch to build the financial investment department.

Peter Lynch can only work harder, while taking care of the overall work, put a little effort into his old business.

The simultaneous formation of multiple divisions and the making of an acquisition plan for Abbott has made Polaris Capital run at high speed.

The preliminary work of the acquisition is bound to take some time, and these are not worthy of Xia Yu's attention.

But he didn't slack off either. He was ready to hurry up and attack Abbott at the same time, targeting the founder of Amgen, Dr. George B. Ratman.

However, he didn't know the big cow, so he came to Genentech and found Professor Herb Boyle in the laboratory.

"Professor Herb Boyle, do you know Dr. George B. Ratman from Abbott?"

Professor Herb Boyle turned off the faucet, dried the water in his hand with a towel, and looked at Xia Yu suspiciously: "Of course I know, he is very good in the field of blood and tumors, we have also discussed in depth together, Mr. Xia , what are you looking for him for?"

Xia Yu nodded slightly and said, "Yes, I think he is a very good scientist. If his research can be realized, it will benefit the world. I want to chat with him and I wonder if you can give me a recommendation?"

Professor Herb Boyle was stunned and said with a smile: "Of course there is no problem. I think Dr. George B. Ratman will be very surprised."

"Of course, I can't think of any reason for him to refuse. After all, every scientist wants to be able to complete his research!"

"Mr. Xia, I'll contact him first, and I'll tell you when I'm sure. Are you free during this time?"

Xia Yu nodded and said, "I'm free at any time, please!"

"No trouble, it's an effort!"

...

Two days later, in a quiet coffee shop in San Francisco, Xia Yu met Dr. George B. Ratman, who was about forty years old.

After leading Xia Yu to meet him, Professor Herb Boyle chatted with Dr. George B. Ratman and left early.

His task has been completed. As for Xia Yu's chat with Dr. George B. Ratman, he felt that it was inconvenient to listen, and his time was precious.

"Dr. Ratman, nice to meet you, my name is Xia Yu, and I am the chairman of Polaris Capital!"

"Hello, Mr. Xia!"

After the two shook hands and said hello, they sat down facing each other, and then each ordered a cup of coffee.

Xia Yu took the lead and said, "Dr. Ratman, I think Professor Herb Boyle should have told you something before, right?"

Thinking of what Professor Herb Boyle said to him when he found him before, Dr. George B. Ratman was slightly excited, nodded and said, "Yes, he told me something."

In fact, when Professor Herb Boyle found him yesterday and told him about this, he was very excited, and he felt like he was stunned by a pie that fell from the sky.

God knows how much he envied Professor Herb Boyle when he learned that Polaris Capital acquired Genentech. He didn't expect that luck would come to him soon after.

And looking at Dr. Latman's expression, Xia Yu also had a certain understanding in his heart, and stated: "Dr. Latman, I have a certain understanding of you, you have a deep research in blood and tumors, and now the world is Scientists in these two fields are far from enough, and countless people have lost their statements because of blood diseases and malignancies, and I hope to do something for the world."

"I listed many scientists in these two fields, but in the end, I chose you for the time being. I think you can be like Professor Herb Boyle, what do you think?"

Xia Yu said this because he didn't want to be too eager, lest George B. Ratman give birth to superfluous thoughts,

affect his interests.

With a serious face, George B. Ratman thanked Xia Yu first, and then said, "Mr. Xia, I am honored to have your approval. I have some research on blood and tumors, and I have also proposed to Abbott. I have applied, but unfortunately I didn't get enough funding."

"I'd love to work with you, but before that, I'd like to hear about your plans."

Xia Yu nodded with a smile: "Of course, it should be."

"We will register a biotechnology company and hire you as the head of scientific research, but you will own the company's equity. As for the shareholding ratio, it will be negotiated based on the value provided by both parties. What do you think?"

After finishing speaking, Xia Yu smiled and looked at Dr. George B. Ratman, who frowned slightly.

Xia Yu didn't want to engage in any venture capital, because he knew the value of Dr. George B. Ratman's head, so he wanted to have a pharmaceutical company as much as possible on the basis of tying Dr. George B. Ratman's head. more equity.

He is not short of money at all. If, like Genentech, a venture capital of $100,000 was invested at the time of its establishment, taking up a small amount of equity, and then spending a lot of money to finance and expand its shares again and again, this would be the least worthwhile.

After all, George B. Ratman is different from Professor Herb Boyle, because when the latter established the company, he was already a Nobel Prize winner, owns certain patents, and is highly sought after by capital.

But George B. Ratman is different. Although he is famous, it is not too big, and he is definitely not as good as the Nobel Prize winner. The second is in patents, and there is no such thing. It is only in blood and Oncology has gone a long way.

The strength of the negotiations is different.

That's why Xia Yu came up with this plan.

It is even more a joke to negotiate equity based on the value provided by both parties. George B. Ratman, who has not yet obtained a patent, will definitely be at a disadvantage. The equity he can get will not be too much, but he has to be tied to the company.

Xia Yu's heart is dark!

Xia Yu's words gradually calmed George B. Ratman's heart. He carefully considered the meaning of Xia Yu's words, and after thinking for a long time, he summoned up the courage to ask: "Mr. Xia, why can't you talk to Genentech? the same?"

Xia Yu spread his hands and said confidently: "Dr. George B. Ratman, you may not know much about us Polaris Capital, we are not that kind of small role, to be humble, we are not poor in money and time. is the most precious."

"Do you hope that the research progress will be slowed down because of the poor scientific research conditions at the beginning?"

"Your age at this time is the peak period of your life. I personally think that you should clear all obstacles for you and be able to devote yourself to research. We are willing to bet for you once!"

When he said this, Xia Yu looked straight into George B. Ratman's eyes.

George B. Ratman looked solemn, and his thoughts struggled from the gains and losses of interests. He thought of the dilemma of insufficient funds that he faced repeatedly when he was at Abbott, and his original intention to engage in scientific research.

After a long time, he looked calm, looked at Xia Yu and said, "Mr. Xia, you are right, for me, time is the most precious thing, just follow your plan, and thank you for your recognition of me! I will do my best not to let you suffer any loss!"

Xia Yu smiled, got up and extended his hand to Dr. George B. Ratman, who also got up and held Xia Yu's hand tightly.

"Then, I wish us a happy cooperation!"

"Happy cooperation!"

...

Dr. George B. Ratman is also the character of Lei Lingfeng, and he also has his own professional ethics. Now that he has decided, he immediately submitted a letter of resignation to Abbott, and then devoted himself to negotiating with Polaris Capital.

The content of the negotiation is very complex, including but not limited to the investment amount, equity distribution, company location and so on.

After three days, all the content was negotiated.

It was finally determined that the new company was called Amgen. Polaris invested 19 million US dollars as the company's start-up capital, and Dr. George B. Ratman invested in shares at his own value, priced at one million US dollars.

Amgen is valued at $20 million, Polaris holds 95 percent, and Dr. George B. Ratman holds 5 percent.

As for the location of the company, it was not San Francisco, but Thousand Oaks, California, which has a strong academic atmosphere and is close to the University of California and California Institute of Technology.

After the company was registered, 19 million US dollars of funds entered the company's account at the first time, and Dr. George B. Ratman went to Thousand Oaks with passion and began to plan and build his own laboratory.

Another biopharmaceutical company with great potential has arrived!

As long as under better conditions, Dr. George B. Ratman is not stupid, then this investment will never be lost!

PS: Please book all the tickets, thank you!

https://

Please remember this book's first domain name: . Apex Novel Mobile Version Reading URL: